Related Experiment Videos
[Microalbuminuria in diabetes: setting the points for treatment]
H Lehnert1, S Klose, R Lobmann
1Coventry University Hospital, UK. hendrik.lehnert@medizin.uni-magdeburg.de
Abstract:
Both type 1 and type 2 diabetes mellitus have a cumulative risk of 25-40% for the development of microalbuminuria 25 years into the disease. In type 2 diabetes micro- and macroangiopathic complications, and frequently hypertension, may also develop. This means that the risk of a type 2 diabetic with microalbuminuria of developing cardiovascular disease is three times greater than that of a diabetic with no renal involvement. Annual screening for microalbuminuria should therefore be obligatory. An increasing albumin excretion rate (AER) is considered an indication for an elevated cardiovascular risk. Studies have shown that the rate of cardiovascular events in diabetics with microalbuminuria and hypertension can be reduced only by the combined treatment of hypertension, hyperglycemia, hyperlipidemia and microalbuminuria.
Related Concept Videos
Diabetic Nephropathy
Nephrotic Syndrome II : Assessment and Medical Management
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Chronic Kidney Disease III: Interprofessional Care
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Nephrotic Syndrome III : Nursing Management